Oral Iptacopan Monotherapy in Paroxysmal Nocturnal Hemoglobinuria
Iptacopan, an oral inhibitor of factor B, increased hemoglobin levels in patients with persistent anemia despite anti-C5 therapy and in patients without previous complement-inhibitor therapy.
Gespeichert in:
Veröffentlicht in: | The New England journal of medicine 2024-03, Vol.390 (11), p.994-1008 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Iptacopan, an oral inhibitor of factor B, increased hemoglobin levels in patients with persistent anemia despite anti-C5 therapy and in patients without previous complement-inhibitor therapy. |
---|---|
ISSN: | 0028-4793 1533-4406 |
DOI: | 10.1056/NEJMoa2308695 |